Allarity Therapeutics (ALLR) Profit After Tax (2020 - 2026)

Allarity Therapeutics (ALLR) has 7 years of Profit After Tax data on file, last reported at -$2.8 million in Q1 2026.

• Quarterly Profit After Tax fell 0.66% year-over-year to -$2.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$11.8 million (up 49.02% YoY) and the FY2025 annual result came in at -$11.9 million, up 51.35% from the prior year.
• Profit After Tax advanced to -$2.8 million in Q1 2026, from -$4.0 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of -$1.6 million in Q4 2022 to a low of -$11.6 million in Q3 2024.
• A 5-year average of -$3.9 million and a median of -$3.1 million in 2022 frame the typical range for Profit After Tax.
• The widest YoY moves for Profit After Tax: up 90.68% in 2022, down 320.43% in 2022.
• Tracing ALLR's Profit After Tax over 5 years: stood at -$1.6 million in 2022, then slipped by 9.89% to -$1.7 million in 2023, then tumbled by 313.12% to -$7.1 million in 2024, then jumped by 43.21% to -$4.0 million in 2025, then jumped by 31.93% to -$2.8 million in 2026.
• The last three Profit After Tax figures came in at -$2.8 million (Q1 2026), -$4.0 million (Q4 2025), and -$2.6 million (Q3 2025), per Business Quant data.